ciprofloxacin has been researched along with penicillin v in 20 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (10.00) | 18.7374 |
1990's | 2 (10.00) | 18.2507 |
2000's | 6 (30.00) | 29.6817 |
2010's | 9 (45.00) | 24.3611 |
2020's | 1 (5.00) | 2.80 |
Authors | Studies |
---|---|
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Caugant, DA; Fredlund, H; Hedberg, ST; Nicolas, P; Olcén, P; Unemo, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Cieslik, W; Jampilek, J; Machura, B; Musiol, R; Nycz, JE; Polanski, J; Vejsova, M; Wolff, M | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Wade, WG | 1 |
Falser, N; Mittermayer, H; Weuta, H | 1 |
Costa, MA; Martins, CA; Nucci, M; Velasco, E | 1 |
Nielsen, PE; Thelle, T; Tvede, M | 1 |
Baumgartner, JD; Cometta, A; Delarive, P; Glauser, MP | 1 |
Huijgens, PC; Janssen, JJ; Leidekker, ME; Simoons-Smit, AM; Timmers, GJ; Vandenbroucke-Grauls, CM | 1 |
Anurathapan, U; Choeyprasert, W; Hongeng, S; Pakakasama, S | 1 |
Bundrick, JB; Edson, RS; Litin, SC | 1 |
Brayden, DJ; Hayden, JC; Maher, S; Takyi, J; Wakai, A; Walsh, SJ | 1 |
Bastiaanssen, TFS; Cryan, JF; Dinan, TG; Fitzgerald, P; Fulling, C; Moloney, GM; O'Connor, R; O'Riordan, KJ; Schellekens, H | 1 |
1 review(s) available for ciprofloxacin and penicillin v
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 trial(s) available for ciprofloxacin and penicillin v
Article | Year |
---|---|
Antibacterial treatment of otitis and sinusitis with ciprofloxacin and penicillin V--a comparison.
Topics: Adult; Bacterial Infections; Ciprofloxacin; Clinical Trials as Topic; Frontal Sinus; Humans; Maxillary Sinus; Otitis Media; Penicillin V; Random Allocation; Sinusitis; Tonsillitis | 1988 |
Randomized trial comparing oral ciprofloxacin plus penicillin V with amikacin plus carbenicillin or ceftazidime for empirical treatment of febrile neutropenic cancer patients.
Topics: Administration, Oral; Adult; Amikacin; Carbenicillin; Ceftazidime; Ciprofloxacin; Costs and Cost Analysis; Drug Therapy, Combination; Female; Fever of Unknown Origin; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Penicillin V; Prospective Studies | 1995 |
Levofloxacin vs. ciprofloxacin plus phenethicillin for the prevention of bacterial infections in patients with haematological malignancies.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fever; Hematologic Neoplasms; Humans; Levofloxacin; Male; Middle Aged; Neutropenia; Ofloxacin; Penicillin V; Treatment Outcome; Viridans Streptococci | 2007 |
16 other study(ies) available for ciprofloxacin and penicillin v
Article | Year |
---|---|
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Antibiotic susceptibility and characteristics of Neisseria meningitidis isolates from the African meningitis belt, 2000 to 2006: phenotypic and genotypic perspectives.
Topics: Africa; Genotype; Humans; Meningitis, Meningococcal; Microbial Sensitivity Tests; Neisseria meningitidis; Phenotype; Sequence Analysis, DNA; Time Factors | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Contribution to investigation of antimicrobial activity of styrylquinolines.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Hydrocarbons, Halogenated; Microbial Sensitivity Tests; Molecular Structure; Quinolines; Structure-Activity Relationship | 2012 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
In-vitro activity of ciprofloxacin and other agents against oral bacteria.
Topics: Bacteria; Ciprofloxacin; Humans; Metronidazole; Microbial Sensitivity Tests; Mouth; Penicillin V; Tetracycline | 1989 |
Recrudescence and relapse of meningococcal meningitis and septicaemia.
Topics: Administration, Oral; Anti-Bacterial Agents; Bacteremia; Child, Preschool; Chloramphenicol; Ciprofloxacin; Female; Follow-Up Studies; Humans; Hydrocortisone; Infant; Injections, Intravenous; Male; Meningitis, Meningococcal; Methylprednisolone; Penicillin G; Penicillin V; Recurrence; Rifampin; Time Factors | 1995 |
[Evaluation of antibiotic prophylaxis in neutropenic patients with hematologic malignancies].
Topics: Adult; Aged; Antibiotic Prophylaxis; Antineoplastic Agents; Bacterial Infections; Ciprofloxacin; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacterial Infections; Hematologic Neoplasms; Humans; Male; Neutropenia; Penicillin V; Retrospective Studies | 2000 |
Bacteremia during neutropenic episodes in children undergoing hematopoietic stem cell transplantation with ciprofloxacin and penicillin prophylaxis.
Topics: Adolescent; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antilymphocyte Serum; Bacteremia; Child; Child, Preschool; Ciprofloxacin; Cord Blood Stem Cell Transplantation; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Neutropenia; Penicillin V; Retrospective Studies; Risk Factors; Young Adult | 2017 |
Clinical Pearls in Infectious Diseases 2017.
Topics: Administration, Intravaginal; Adult; Aged; Anti-Bacterial Agents; Body Piercing; Campylobacter Infections; Campylobacter jejuni; Cellulitis; Ciprofloxacin; Communicable Diseases; Cyanosis; Diarrhea; Dietary Fiber; Drug Therapy, Combination; Estrogens; Female; Helicobacter Infections; Humans; Lyme Disease; Male; Metronidazole; Middle Aged; Otitis; Penicillin V; Phenazopyridine; Proton Pump Inhibitors; Tetracycline; Tick Bites; Travel-Related Illness; Urinary Tract Infections; Young Adult | 2017 |
Effect of Overencapsulation on the Disintegration and Dissolution of Licensed Formulations for Blinding in Randomized Controlled Trials.
Topics: Chemistry, Pharmaceutical; Ciprofloxacin; Drug Compounding; Drug Liberation; Excipients; Furosemide; Gemfibrozil; Penicillin V; Randomized Controlled Trials as Topic; Solubility; Tablets | 2019 |
Maternal antibiotic administration during a critical developmental window has enduring neurobehavioural effects in offspring mice.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Anxiety; Ciprofloxacin; Cognition; Female; Homing Behavior; Imipenem; Male; Metronidazole; Mice; Mice, Inbred C57BL; Penicillin V; Pregnancy; Prenatal Exposure Delayed Effects; Social Behavior; Vancomycin; Vocalization, Animal | 2021 |